Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant. (Q51201626)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 January 2017
edit
Language Label Description Also known as
English
Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant.
scientific article published on 10 January 2017

    Statements

    Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit